Cargando…

Influence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review

BACKGROUND: Hyperphosphatemia is one of the common complications in patients undergoing hemodialysis. Although calcium carbonate (CaC) is often used to control serum inorganic phosphorus level in dialysis patients, co-administration of gastric acid reducers (ARs) may interfere with the phosphate bin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatsuzawa, Masaomi, Ogawa, Ryuichi, Ohkubo, Atsushi, Shimojima, Kazuyo, Maeda, Kunimi, Echizen, Hirotoshi, Miyazaki, Akihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120546/ https://www.ncbi.nlm.nih.gov/pubmed/27895933 http://dx.doi.org/10.1186/s40780-016-0068-1

Ejemplares similares

Consequences of Different Corticosteroids on Serum Potassium and Prostate-Specific Antigen in Patients Receiving Abiraterone for Castration-Resistant Prostate Cancer: A Retrospective Observational Study
por: Tatsuzawa, Masaomi, et al.
Publicado: (2017)

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study
por: Ogawa, Chie, et al.
Publicado: (2020)

Impact of Pharmacists’ audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective study
por: Shimizu, Teppei, et al.
Publicado: (2017)

Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study
por: Ogawa, Chie, et al.
Publicado: (2022)

A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients
por: Ogawa, Chie, et al.
Publicado: (2020)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients
por: Cekiç, Deniz, et al.
Publicado: (2023)

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study
por: Ogawa, Chie, et al.
Publicado: (2017)

Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Comparison and Analysis of Delirium Induced by Histamine H(2) Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients
por: Fujii, Shiro, et al.
Publicado: (2012)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
por: Kweon, Takhyeon, et al.
Publicado: (2023)

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?
por: De Benedetto, Anna, et al.
Publicado: (2015)

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012)

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
por: Liu, Peipei, et al.
Publicado: (2020)

Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.
por: Van der Ven, L. T., et al.
Publicado: (1993)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2011)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro
por: Lepczyńska, Małgorzata, et al.
Publicado: (2021)

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H(2) Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis
por: Gao, Jiamin, et al.
Publicado: (2022)

Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010)

In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020)

Effects of histamine and various histamine receptor antagonists on gene expression profiles of macrophages during compressive strain
por: Schröder, Agnes, et al.
Publicado: (2021)

Prolonged Use of Proton Pump Inhibitors, but Not Histamine-2 Receptor Antagonists, Is Associated With Lower Bone Mineral Density in Males Aged Over 70
por: Gao, Shihua, et al.
Publicado: (2021)

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs
por: Mottaghi, Batoul, et al.
Publicado: (2021)

Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review
por: Begg, Maha, et al.
Publicado: (2023)

Histamine H1 antagonists and clinical characteristics of febrile seizures
por: Zolaly, Mohammed A
Publicado: (2012)

Multiple Targeting Approaches on Histamine H(3) Receptor Antagonists
por: Khanfar, Mohammad A., et al.
Publicado: (2016)

Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement
por: Sperl, Gregor, et al.
Publicado: (2020)

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
por: Ogawa, Chie, et al.
Publicado: (2023)

Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Nonaka, Takashi, et al.
Publicado: (2011)

Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B(12) Depletion
por: Zdilla, Matthew J.
Publicado: (2015)

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Anticonvulsant effects of isomeric nonimidazole histamine H(3) receptor antagonists
por: Sadek, Bassem, et al.
Publicado: (2016)

The General Use of Histamine Antagonists: With Special Reference to Therapy in Dermatological Disorders
por: Warin, Robert P.
Publicado: (1950)

Suppression of IFN-γ Production in Murine Splenocytes by Histamine Receptor Antagonists
por: Kamei, Miho, et al.
Publicado: (2018)

Developmental changes of fluconazole clearance in neonates and infants in relation to ontogeny of glomerular filtration rate: literature review and data analysis
por: Murakoso, Kazutoshi, et al.
Publicado: (2018)

The Histamine H(4) Receptor Participates in the Neuropathic Pain-Relieving Activity of the Histamine H(3) Receptor Antagonist GSK189254
por: Borgonetti, Vittoria, et al.
Publicado: (2022)

Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis
por: Kondo, Yutaka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5igvjkge1ioqehm2ps9jp6g9vl